Results 171 to 180 of about 69,334 (300)

Establishment and characterization of mouse lymph node fibrosis models

Animal Models and Experimental Medicine, EarlyView.
The design of the entire paper. Schematic illustration of four strategies for establishing mouse lymph node (LN) fibrosis models. The study further compares their fibrotic remodeling patterns and immune alterations. Abstract Background Lymph node (LN) fibrosis occurs in a variety of pathological conditions, including HIV infection, obesity, cancer, and
Yaru Niu, Xu Guan, Jian Ma, Xin Zhang, Yihang Shi, Jinzhu Zhang, Leiqiong Gao, Wei Chen, Xishan Wang   +8 more
wiley   +1 more source

Comparison of the protective effect of human respiratory syncytial virus Pre-F protein combined with different adjuvants in BALB/c mice. [PDF]

Front Immunol
Chu M, Du L, Hu H, Cao L, Zhang L, Mao N, Zhu Z, Zhang Y, Li H.   +8 more
europepmc   +1 more source

Plant Virus Immunotherapy for HPV‐Associated Oropharyngeal Squamous Cell Carcinoma

Advanced NanoBiomed Research, EarlyView.
Cowpea mosaic virus (CPMV) nanoparticles are safe and potent cancer immunotherapy candidates with strong immunomodulatory activity. CPMV activates innate immunity, which in turn drives adaptive immune responses and promotes durable, systemic antitumor effects.
Jessica Fernanda Affonso de Oliveira, Patrick Opdensteinen, Andrea Simms, Seongwon Jung, Giuliana P. Mognol, Hui Chen, Judith A. Varner, Nicole F. Steinmetz   +7 more
wiley   +1 more source

Research developments in nanobiomaterials for tumor vaccines: A review. [PDF]

Medicine (Baltimore)
Dai H, Kong W, Liu T, Fei X.
europepmc   +1 more source

Rewriting Tumor Immunity With Bacterial Membrane Vesicles: A Versatile and Potent Therapeutic Strategy

Advanced NanoBiomed Research, EarlyView.
Bacterial membrane vesicles (BMVs) emerge as promising platforms for cancer immunotherapy owing to their intrinsic adjuvant properties and tunable cargo delivery capabilities. Their ability to modulate the tumor microenvironment, enhance antitumor immune responses, and support personalized therapeutic strategies highlights their growing potential as ...
Md Sifat Rahi, Md Mijanur Rahman, Asma Talukder, Urooj Yousaf Virk, Jennifer C. Wilson, Nigel McMillan, Ming Q. Wei   +6 more
wiley   +1 more source

Vaxjo 2.0: An ontology- and large language model-powered knowledge base of vaccine adjuvants and mechanisms. [PDF]

Front Cell Infect Microbiol
Monickaraj J, Rehana H, Bernardi A, Zheng Y, Lin T, Liu L, Madireddi A, Yeh L, Zheng J, Hur J, He Y.   +10 more
europepmc   +1 more source

The Road toward a Trojan Horse Malaria Vaccine: Chemical Augmentation of Live Sporozoites without Affecting Their Viability. [PDF]

Mol Pharm
Naar CM, van Schuijlenburg R, van Meerbeek M, Chevalley-Maurel S, Zigó LA, Franke-Fayard B, van Leeuwen FWB, Roestenberg M.   +7 more
europepmc   +1 more source

Correction: Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations. [PDF]

Front Immunol
Coria LM, Pueblas Castro C, Bruno L, Nakaya HI, Pasquevich KA, Cassataro J.   +5 more
europepmc   +1 more source

Injection of Leukocyte‐Poor Platelet‐Rich Plasma During Rotator Cuff Repair Can Increase Healing Rate but Does Not Affect Clinical Outcomes: A Systematic Review and Meta‐analysis of Randomized Controlled Trials

Arthroscopy, EarlyView.
Purpose To evaluate the efficacy of injected leukocyte‐poor platelet‐rich plasma (LP‐PRP) during arthroscopic rotator cuff repair, primarily in reducing failure rates and, secondarily, in improving shoulder function and clinical outcome. Methods A systematic review was performed in accordance with the Preferred Reporting Items for Systematic Review and
Charalampos Pitsilos, Dimitrios Rigkos, Byron Chalidis   +2 more
wiley   +1 more source

An old foe comes swooping back: Whooping cough resurgence-Okay, now what? [PDF]

PLoS Pathog
Musgrave DL, Creech CB.
europepmc   +1 more source